Aravive, Inc. – Platinum Resistant Ovarian Cancer
Gail McIntyre, CEO of Aravive, Inc., discusses the urgent need for improved therapeutic approaches to treat patients with ovarian cancer who are resista...
295 articles
Gail McIntyre, CEO of Aravive, Inc., discusses the urgent need for improved therapeutic approaches to treat patients with ovarian cancer who are resista...
Luis Raez, Chief Scientific Officer and Medical Director, Memorial Cancer Institute/Memorial Health Care System in Pembroke Pines, Florida, discusses a ...
Danielle Hicks, Chief Patient Officer at the GO2 Foundation for Lung Cancer shares her personal story of becoming a caregiver for her mother when she wa...
Sheri Prentiss, MD, best selling author and Certified Physician Executive, discusses her own personal breast cancer story and her partnership with medte...
David Feldman, MD, MBA, FACS, Chief Medical Officer of The Doctors Company Group, a physician-owned, medical malpractice insurer, and for the TDC Grou...
Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses the Oncotype MAP™ Pan-Cancer Tissue test for patients with a...
Pritesh Shah, Chief Commercial Officer of device maker Novocure® discusses Tumor Treating Fields, a cap-like device that aims electric fields at cancer...
David Spetzler, President and Chief Scientific Officer of Caris Life Sciences, discusses the company's launch of CODEai™(Comprehensive Oncology Data E...
Susan, a woman living with an NTRK gene fusion, a rare genomic driver that drove her thyroid cancer shares her unique cancer journey and how she benefit
Jim Palma, Executive Director at TargetCancer Foundation discusses a new clinical trial called TRACK (TargetRare Cancer Knowledge).